Improved outcome with pulses of vincristine and corticosteroids in continuation therapy of children with average risk acute lymphoblastic leukemia (ALL) and lymphoblastic non-Hodgkin lymphoma (NHL): report of the EORTC randomized phase 3 trial 58951

類似資料

• Dexamethasone (6 mg/m(2)/day) and prednisolone (60 mg/m(2)/day) were equally effective as induction therapy for childhood acute lymphoblastic leukemia in the EORTC CLG 58951 randomized trial
  著者:: Domenech, Carine, 等
  出版事項: (2014)
• Prolonged versus standard native E. coli asparaginase therapy in childhood acute lymphoblastic leukemia and non-Hodgkin lymphoma: final results of the EORTC-CLG randomized phase III trial 58951
  著者:: Mondelaers, Veerle, 等
  出版事項: (2017)
• CD200/BTLA deletions in pediatric precursor B-cell acute lymphoblastic leukemia treated according to the EORTC-CLG 58951 protocol
  著者:: Ghazavi, Farzaneh, 等
  出版事項: (2015)
• French “real life” experience of clofarabine in children with refractory or relapsed acute lymphoblastic leukaemia
  著者:: Trioche, Pascale, 等
  出版事項: (2012)
• Dexamethasone compared to prednisolone for adults with acute lymphoblastic leukemia or lymphoblastic lymphoma: final results of the ALL-4 randomized, phase III trial of the EORTC Leukemia Group
  著者:: Labar, Boris, 等
  出版事項: (2010)